title: Effects of the RBC membrane and increased perfusate viscosity on hypoxic pulmonary vasoconstriction.
abstract: Red blood cells (RBCs) augment hypoxic pulmonary vasoconstriction (HPV) in part by scavenging of nitric oxide (NO) by Hb (Deem S, Swenson ER, Alberts MK, Hedges RG, and Bishop MJ, Am J Respir Crit Care Med 157: 1181-1186, 1998). We studied the contribution of the RBC compartmentalization of Hb to augmentation of HPV and scavenging of NO in isolated perfused rabbit lungs. Lungs were initially perfused with buffer; HPV was provoked by a 5-min challenge with hypoxic gas (inspired O(2) fraction 0.05). Expired NO was measured continuously. Addition of free Hb to the perfusate (0.25 mg/ml) resulted in augmentation of HPV and a fall in expired NO that were similar in magnitude to those associated with a hematocrit of 30% (intracellular Hb of 100 mg/ml). Addition of dextran resulted in a blunting of HPV after free Hb but no change in expired NO. Blunting of HPV by dextran was not prevented by NO synthase inhibition with N(omega)-nitro-L-arginine and/or cyclooxygenase inhibition. RBC ghosts had a mild inhibitory effect on HPV but caused a small reduction in expired NO. In conclusion, the RBC membrane provides a barrier to NO scavenging and augmentation of HPV by Hb. Increased perfusate viscosity inhibits HPV by an undetermined mechanism.
authors.affiliation: Departments of Anesthesiology and Medicine, University of Washington, Washington 98195, USA. sdeem@u.washington.edu
authors.forename: S
authors.initials: S
authors.lastname: Deem
authors.forename: J T
authors.initials: JT
authors.lastname: Berg
authors.forename: M E
authors.initials: ME
authors.lastname: Kerr
authors.forename: E R
authors.initials: ER
authors.lastname: Swenson
mesh_terms: D000818:Animals; D016861:Cyclooxygenase Inhibitors / Q000494:pharmacology; D003911:Dextrans / Q000494:pharmacology; D004910:Erythrocyte Membrane / Q000502:physiology*; D006454:Hemoglobins / Q000494:pharmacology; D000860:Hypoxia / Q000097:blood / Q000503:physiopathology*; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors; D019335:Nitroarginine / Q000494:pharmacology; D010477:Perfusion; D011652:Pulmonary Circulation / Q000187:drug effects; D011817:Rabbits; D012119:Respiration; D014661:Vasoconstriction / Q000187:drug effects; D014783:Viscosity
chemical_list: D016861:Cyclooxygenase Inhibitors; D003911:Dextrans; D006454:Hemoglobins; D019335:Nitroarginine; D009569:Nitric Oxide; D019001:Nitric Oxide Synthase